Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Role of multisegmental nerve ultrasound in the diagnosis of leprosy neuropathy

De Martino Luppi A, Ferreira GE, Borges IS, et al. Public Library of Science (PLoS). PLOS ONE. 2024; 19 (7) : 1-15.
Download PDF
Publication

Childhood leprosy in Buenos Aires: four cases report

Merenzon S, L. Costa A, Frare C, et al. Sociedad Argentina de Pediatria. Archivos Argentinos de Pediatria. 2024; 122 (6) : 1-6.
Download PDF
Publication

Leprosy Presenting With Scleroderma and Cataract: A Clinical Conundrum

Ahmed S, Patel M, Chakole S, et al. Springer Science and Business Media LLC. Cureus. 2024;
Download PDF
Publication

Vitiligo after borderline lepromatous leprosy: common immunological implications

Sequeira CM, Cupertino F, Cunha JM, et al. Publicidad Permanyer, SLU. Portuguese Journal of Dermatology and Venereology. 2024;
Download PDF
Publication

Anetoderma as an initial presentation of leprosy in a patient with prolonged steroid use

Soares‐Neto RF, Ramalho ARDO, Tenório MDL, et al. Wiley. Australasian Journal of Dermatology. 2024;
Publication

Nódulos infecciosos en dermatología, un desafío para el clínico: a propósito de un caso importado de lepra histioide en Chile

Jimeno-Ortega I, Martinez V, Fernanda Flores M, et al. Revista Chilenda de Dermatología. 2022;
Download PDF
Publication

Leprosy knowledge among primary care physicians in Southern Brazil: are we underdiagnosing?

de Cássia Francisco P, Kliemann BS, Tarlé RG. Wiley. International Journal of Dermatology. 2024;
Publication

A Retrospective Review of Neglected Tropical Diseases Diagnosed on Histopathological Specimens in the Free State Province, South Africa, 2015-2020.

le Grange D, Pillay S, Budding L, et al. Journal of tropical medicine. 2024;
Download PDF
Publication

Case Report: Nonalcoholic Hepatic Steatosis Associated with Type-2 Leprosy Reaction.

Orozco K, Cubillos J, Genes M, et al. The American journal of tropical medicine and hygiene. 2024;
Publication

Long-term storage stability of PGL-I coated ELISA plates for anti-Mycobacterium leprae IgM detection.

Fogaça M, Saavedra D, Sousa M, et al. Journal of microbiological methods. 2024;

Pagination

  • Previous page ‹‹
  • Page 21
  • Next page ››
Subscribe to Diagnosis

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD